The Wellcome Trust – MRC Cambridge Stem Cell Institute marked a major milestone this month with the topping out of its new purpose-built home on the Cambridge Biomedical Campus.
Construction of the 18,000sqm, £94million facility is due to be completed in late 2018, when all 29 research groups that make up the Cambridge Stem Cell Institute will move in.
The move will result in a fully integrated, vibrant and cohesive hub for the Cambridge Stem Cell Community, with the new building ideally placed in the unique intellectual and clinical environment of the Cambridge Biomedical Campus.
Professor Tony Green, Director of the Institute said “Next year we will move into our new home on the Cambridge Biomedical Campus. Having all of our scientists co-located in a single new building will be a step-change for stem cell research in Cambridge.”
The mission of the Cambridge Stem Cell Institute is to transform the prevention, diagnosis and treatment of disease through a deep understanding of the mechanisms regulating stem and progenitor cells, both normal and pathological.
To achieve this aim, the Institute takes a collaborative approach, bringing together biological, clinical and physical scientists operating across a wide range of tissues, thus allowing commonalities and differences in stem cell biology to be explored in a cohesive manner.
The Cambridge Stem Cell Institute is generously supported by the Wellcome Trust and the Medical Research Council who have jointly supported the Institute since 2012. They will share their new building with Cambridge Institute of Therapeutic Immunology and Infectious Diseases (CITIID) and the Milner Therapeutics Institute, both of whom have explicitly translational goals.